Department of Health and Human Services August 22, 2023 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Activities: Proposed Collection: Public Comment Request Information Collection Request Title: National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners
Document Number: 2023-17987
Type: Notice
Date: 2023-08-22
Agency: Department of Health and Human Services, Health Resources and Services Administration
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
Oncologic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
Document Number: 2023-18024
Type: Notice
Date: 2023-08-22
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Oncologic Drugs Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Health Workforce Connector OMB No. 0906-0031 Revision
Document Number: 2023-18007
Type: Notice
Date: 2023-08-22
Agency: Department of Health and Human Services, Health Resources and Services Administration
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
National Vaccine Injury Compensation Program; List of Petitions Received
Document Number: 2023-18003
Type: Notice
Date: 2023-08-22
Agency: Department of Health and Human Services, Health Resources and Services Administration
HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the Program), as required by the Public Health Service (PHS) Act, as amended. While the Secretary of HHS is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions.
Notice of Award of President's Emergency Plan for AIDS Relief (PEPFAR) Funding To Strengthen Health Workforce Efforts in the Democratic Republic of Congo (DRC)
Document Number: 2023-18001
Type: Notice
Date: 2023-08-22
Agency: Department of Health and Human Services, Health Resources and Services Administration
HRSA will award $2 million in PEPFAR funding for work in DRC to strengthen pre-service education primarily focusing on nursing and midwifery competencies through student clinical rotations and community health work.
Solicitation of Nominations for Membership To Serve on the Advisory Commission on Childhood Vaccines
Document Number: 2023-17999
Type: Notice
Date: 2023-08-22
Agency: Department of Health and Human Services, Health Resources and Services Administration
HRSA is seeking nominations of qualified candidates for consideration for appointment as members of the Advisory Commission on Childhood Vaccines (ACCV). ACCV advises the Secretary of HHS (the Secretary) on issues related to the implementation of the National Vaccine Injury Compensation Program (VICP).
Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability
Document Number: 2023-18026
Type: Notice
Date: 2023-08-22
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing the availability of additional draft and revised draft product-specific guidances. The guidances provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs). In the Federal Register of June 11, 2010, FDA announced the availability of a guidance for industry entitled ``Bioequivalence Recommendations for Specific Products'' that explained the process that would be used to make product-specific guidances available to the public on FDA's website. The guidances identified in this notice were developed using the process described in that guidance.
Supplemental Award; Infant-Toddler Court Program-National Resource Center
Document Number: 2023-18051
Type: Notice
Date: 2023-08-22
Agency: Department of Health and Human Services, Health Resources and Services Administration
HRSA is providing approximately $1.91 million in supplemental award funds under HRSA-22-074 in fiscal year 2023 to the recipient of the Infant-Toddler Court Program (ITCP)National Resource Center (NRC) award, to support state and local capacity to implement the ITC approach at sites that previously received funding under HRSA-18-123 but that do not currently receive HRSA funding under HRSA-22-073 or HRSA-22-074. It is also providing approximately $650,000 in supplemental award funds under this notice of funding opportunity (NOFO) to support ITC sites with high need and capacity to provide Medicaid redetermination navigation support to families.
National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings
Document Number: 2023-18037
Type: Notice
Date: 2023-08-22
Agency: Department of Health and Human Services, National Institutes of Health
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.